EADV Symposium scientific programme
The EADV Scientific Programming Committee has prepared a captivating and inspiring 3-day agenda that caters to the expectations of both young dermatologists-venereologists and seasoned professionals.
The specially curated programme promises an intimate experience with renowned speakers across 28 sessions.
Session types
Sessions of different formats will cover the most important topics in dermatology and venereology. Subjects will be treated with different approaches and from different perspectives depending on the type and structure of the session.
Plenary sessions ↓
The Plenary lectures are EADV show-case sessions and include key-note lectures delivered by eminent scientists and doctors.
What's new ↓
These sessions will enable participants to update their knowledge on a specific topic and hear about the most relevant and recent developments, guidelines and practical knowledge from the past year. The talks will summarize the current understanding of the subject, followed by an update on the most recent novelties with their impact on clinical practice.
Focus on ↓
These sessions aim at providing comprehensive in-depth coverage of a certain topic in dermatology. The talks will be included in sessions on pathophysiology / epidemiology, clinical challenges, or practical aspects of disease management and will provide the latest cutting-edge information.
Interactive clinical cases ↓
These lectures focus on a specific disease and include basic information about epidemiology, pathophysiology, diagnosis, management and prognosis.
The target audience of these sessions is young dermatology trainees and residents, as well as dermatologists that want to refresh their basic knowledge on specific topics.
The topic of each presentation should be developed from clinical cases and include clinical photographs. The main objective is to provide the audience clues for differential diagnosis and disease management in their daily practice.
Each presentation is supposed to be interactive, with multiple-choice question made to the audience in accordance with the subjects treated in the talks. Each speaker will be asked to include 2-3 questions by “data” along with the different answers’ options.
Free communications ↓
Authors of the most highly-ranked abstracts assessed by a selected panel of abstract reviewers are invited to a provide a 10-minute oral presentation.
Programme at a glance
Thursday, 22 May 2025
14:00 - 15:30
Melanoma
New targeted treatment:
Inflammatory diseases
Free communications 1
15:45 - 17:15
Keratinocytic skin cancer
New targeted treatment:
Inflammatory diseases
Free communications 2
17:30 - 18:30
Plenary session
Friday, 23 May 2025
09:00 - 10:30
Adverse anti-cancer drug reactions
Dermoscopy
New targeted treatment:
Inflammatory diseases
10:45 - 12:15
Hidradenitis suppurativa
Clinical-pathological correlations
New targeted treatment: Skin cancer
12:45 - 13:45
Industry sessions
14:00 - 15:30
Emergencies in dermatology
Hair and nail disorders
Viral infections:
Emerging threats
15:45 - 17:15
Regenerative medicine and aesthetics
Residents quiz the faculty
Viral infections:
Viruses and cancer
Saturday, 24 May 2025
09:00 - 10:30
Hair and Nails
Psoriasis
Viral infections:
Viruses and exanthema
10:45 - 12:15
Aesthetic dermatology
Genodermatoses
Viral infections:
Viruses and drugs
12:30 - 14:00
Paediatric dermatology
Joint EADV-IUSTI-EU Session on Venereology
Connective tissue diseases
Sessions spotlights
Hair and nail disorders
Interactive clinical cases
- Fri 23 May
- 14:00 - 15:30 CEST
- South Hall 2
- Chair


Scarring alopecia
Matilde Iorizzo, Switzerland
Lecture description
Scarring alopecia is a disease that is sometimes difficult to diagnose and treat. Cases of scarring alopecia in adult patients, from diagnosis to treatment, will be presented to give the audience insights on how to manage these difficult patients.
Learning objectives
- Identify and differentiate subtypes of scarring alopecia
- Interpret trichoscopy results
- Develop tailored management plans


Non-scarring alopecia
Anastasia Therianou, United Kingdom
Lecture description
This is an interactive session where interesting cases of non- scarring alopecias are going to be presented.
Non-scarring alopecias such as female pattern hair loss, telogen effluvium or alopecia areata and many more, are very common in everyday clinical practice, however sometimes it is hard to make the diagnosis and arrange a management plan.
Through the presentation of 5-7 clinical cases (with medical history, clinical and dermoscopical images), the audience will be able to learn on how to successfully diagnose different types of non-scarring alopecia and how to successfully manage them.
Learning objectives
- Learn how to diagnose and manage some interesting non-scarring alopecia cases
- Chair


Hair and nail disorders in systemic diseases
Alexander Katoulis, Greece
Lecture description
Skin, including hair and nails, are rightly described as “windows” to systemic diseases, as they frequently display visible clues reflecting underlying conditions. This clinical case-based presentation explores the diagnostic significance of hair and nail manifestations in systemic disorders, highlighting the diagnostic and therapeutic complexities.
Systemic or auto-inflammatory diseases may affect also the scalp, causing secondary scarring alopecia, providing insights for the primary disease diagnosis and treatment. Especially hair involvement (non-scarring alopecia, lupus hair and chronic telogen effluvium) plays an important diagnostic role in systemic lupus erythematosus (SLE), representing one of the diagnostic criteria for SLE.
Internal cancer may manifest itself in multiple ways through hair: skin metastases from breast or lung cancer may appear as patches of alopecia; acquired hair disorders, such as hypertrichosis lanuginosa, represent paraneoplastic syndromes serving as markers of internal malignancy; chemotherapy-induced alopecia is the most distressing adverse reaction of cytotoxic chemotherapy; modern immunotherapy and targeted therapies for advanced neoplasms are not uncommonly associated with autoimmune hair disorders; and secondary scarring alopecia may develop at the sites of radiotherapy treatment.
Nail abnormalities, including changes in shape, texture, and color, often reflect systemic pathologies. Systemic illnesses, such as cardiovascular diseases, may cause splinter hemorrhages, while clubbing can signal chronic pulmonary disorders. Yellow nail syndrome is associated with lymphedema and respiratory conditions, and koilonychia may indicate iron deficiency anemia. Terry’s white nails are commonly linked to liver cirrhosis, congestive heart failure, or diabetes. Beau’s transverse lines of the nail plate, often reflect periods of systemic stress, such as severe illness or malnutrition.
Hair and nail manifestations provide vital diagnostic and prognostic insights into systemic diseases. Recognizing these signs can facilitate early diagnosis and tailored management of conditions like lupus and cancer. Future directions in this domain include the development of targeted therapies to mitigate treatment-induced hair and nail changes and the integration of trichoscopy and dermoscopy into routine clinical practice. Clinicians equipped with the tools to identify and manage hair and nail manifestations in systemic diseases can foster a multidisciplinary approach to patient care.
Learning objectives
- Identify visible signs of systemic diseases in hair and nails
- Recognize the diagnostic value of hair and nail abnormalities in systemic conditions
- Assess the diagnostic importance of observing hair and nail changes during clinical evaluations
- Integrate observations of hair and nail changes into holistic patient evaluations


Dystrophic nails
Marcel Pasch, Netherlands
Lecture description
Disease management for patients with dystrophic nails can be bothersome and sometimes frustrating in daily practice. To an untrained eye, many nail dystrophies look alike but successful treatment depends first and foremost on a correct diagnosis.
Numerous causes can be responsible for disruption of normal nail growth, with infectious (onychomycosis), inflammatory (lichen planus, psoriasis, alopecia areata), traumatic (onychotillomania) and oncologic (melanoma, squamous cell carcinoma) being the most frequent. Participants in this session will be taken through history taking, investigations, diagnosis and management in an interactive manner with interactive polls.
Through clinical cases with detailed clinical photographs, tools will be provided that will make the correct diagnosis and effective treatment of patients with nail dystrophy much easier than generally thought. In a number of patients, we will also discuss pitfalls that you do not want to miss and may serve as red flags that require immediate action.
Learning objectives
- Successful treatment of nail dystrophy depends on a correct diagnosis.
- The most frequent causes for nail dystrophy are infectious (onychomycosis), inflammatory (lichen planus, psoriasis, alopecia areata), traumatic (onychotillomania) and oncologic (melanoma, squamous cell carcinoma).
- Making the correct diagnosis and effective treatment of patients with nail dystrophy is easier than generally thought.
- Some clinical signs in nail dystrophy can serve as red flags requiring prompt action.
Dermoscopy
Interactive clinical cases
- Fri 23 May
- 09:00 - 10:30 CEST
- South Hall 2
- Chair


Pink/Red
Caterina Longo, Italy


Blue/Violet
Pedro Zaballos, Spain


Yellow/Orange
Ofer Reiter Agar , Israel
Lecture description
This session focuses on the use the color as a clue for clinical and dermoscopic diagnosis. The presentation will cover tumors where yellow (keratin and lipids; tumors with sebaceous differentiation, juvenile xanthogranuloma, granular tumors, sarcoidosis) and orange color (granulomatous skin diseases) are key findings.
Learning objective
- Learn the differential diagnosis of skin tumors presenting yellow and orange color
- Chair


Brown/Black
Monika Arenbergerova, Czechia
Lecture description
The colors are fundamental in dermoscopic evaluation. Most of the colors present on the skin originate from an increase of a specific chromophore in skin tissue, such as pigment (brown, black, gray, blue), keratin (yellow), collagen (white), or haemoglobin (red, black). The most important chromophore in pigmented lesions is melanin. Black coloring in dermoscopy appears when melanin is present in the stratum corneum or the upper epidermis; brown coloring appears when melanin is located in the mid or low epidermis. Black coloring revealed by dermoscopy does not always imply ominous conditions. Lesions which are black in dermoscopy can be of benign as well as malignant origin. Black coloring appears in melanocytic naevus (especially Reed naevus), seborrheic keratosis, thrombosed haemangioma, subcorneal haematoma, but also in melanoma and heavily pigmented basal cell carcinoma. The presentation will cover theoretical but also practical knowledge on dermoscopy of brown and black lesions.
Learning objectives
- Identify and differentiate black and brown colors in dermoscopy to distinguish between malignant and benign lesions.
Letter from the Chair of the EADV Scientific Programming Committee
Dear Colleagues,
Prof. Michel Gilliet
Chair of the SPC


Scientific Programming Committee: Michel Gilliet (Chair of the SPC), Jo Lambert, Paola Pasquali, Lidia Rudnicka, Eli Sprecher, Thrasyvoulos Tzellos
If you have any further questions about the Scientific Programme, Abstracts, CME Accreditation, or Certificates, please contact us at [email protected]